KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $209,296 | +12.5% | 10,608 | 0.0% | 0.00% | – |
| Q4 2023 | $186,065 | +1.0% | 10,608 | 0.0% | 0.00% | – |
| Q3 2023 | $184,261 | +61.4% | 10,608 | 0.0% | 0.00% | – |
| Q2 2023 | $114,143 | 0.0% | 10,608 | 0.0% | 0.00% | – |
| Q1 2023 | $114,143 | -74.6% | 10,608 | -64.6% | 0.00% | – |
| Q4 2022 | $449,521 | -99.9% | 30,008 | 0.0% | 0.00% | – |
| Q3 2022 | $385,302,000 | +12.0% | 30,008 | -15.4% | 0.00% | – |
| Q2 2022 | $343,898,000 | -2.5% | 35,490 | 0.0% | 0.00% | – |
| Q1 2022 | $352,771,000 | -15.5% | 35,490 | 0.0% | 0.00% | – |
| Q4 2021 | $417,717,000 | +3.3% | 35,490 | 0.0% | 0.00% | – |
| Q3 2021 | $404,231,000 | – | 35,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |